Login / Signup

Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.

Pengfei WangĐani ŠkalameraXianwei SuiPing ZhangSuzanne M Michalek
Published in: ACS infectious diseases (2019)
We have designed and synthesized two analogs (5 and 6) of QS-7, a natural saponin compound isolated from Quillaja saponaria (QS) Molina tree bark. The only structural difference between compound 5 and 6 is that 5 is acetylated at the 3- and 4-O positions of the quillaic acid C28 fucosyl unit while 6 is not. However, the two analogs show significantly different immunostimulant profiles. Compound 5 may potentiate a mixed Th1/Th2 (Th, T helper cells) immune response against the specific antigens while compound 6 may only induce a Th2-biased immunity. These results suggest that the 3- and/or 4-O acetyl groups of the fucosyl unit may play an important role in tuning the adjuvanticity of the QS-7 analogs, and compound 5 can serve as a structurally defined synthetic adjuvant when a mixed Th1/Th2 immune responses is desired.
Keyphrases
  • immune response
  • dendritic cells
  • molecular docking
  • induced apoptosis
  • early stage
  • toll like receptor
  • regulatory t cells
  • cell proliferation
  • inflammatory response
  • molecular dynamics simulations
  • signaling pathway